Chondroitin Industry Research Report 2024

Chondroitin Industry Research Report 2024


Summary

Chondroitin is a chondrin derivative, generally is Chondroitin sulfate.
Chondroitin sulfate is a sulfated glycosaminoglycan (GAG) composed of a chain of alternating sugars (N-acetylgalactosamine and glucuronic acid). It is usually found attached to proteins as part of a proteoglycan. A chondroitin chain can have over 100 individual sugars, each of which can be sulfated in variable positions and quantities. Chondroitin sulfate is an important structural component of cartilage and provides much of its resistance to compression. Along with glucosamine, chondroitin sulfate has become a widely used dietary supplement for treatment of osteoarthritis.
According to APO Research, the global Chondroitin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Chondroitin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Chondroitin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Chondroitin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Chondroitin include SANXIN, Focus Chem, GGI, Guanglong Biochem, Hengjie Bio-Pharmaceuticals, Huiwen, ISBA, Jiaixng Hengjie and Meitek, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Chondroitin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chondroitin.
The report will help the Chondroitin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Chondroitin market size, estimations, and forecasts are provided in terms of sales volume (Ton) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Chondroitin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

SANXIN
Focus Chem
GGI
Guanglong Biochem
Hengjie Bio-Pharmaceuticals
Huiwen
ISBA
Jiaixng Hengjie
Meitek
Nippon Zoki
Pacific Rainbow
Qingdao Green-Extract
QJBCHINA
Runxin Biotechnology
SANXIN GROUP
Shandong Dongcheng
Sioux Pharm
Summit Nutritionals
TSI Group
WanTuMing Biological
Yantai Dongcheng
YBCC
Yibao Group
Chondroitin segment by Type

Food Grade
Pharmaceutical Grade
Chondroitin segment by Application

Pharmacy
Health Products
Chondroitin Segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chondroitin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Chondroitin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chondroitin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Chondroitin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Chondroitin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Chondroitin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Chondroitin Market Size (2019-2030) & (US$ Million)
2.2.2 Global Chondroitin Sales (2019-2030)
2.2.3 Global Chondroitin Market Average Price (2019-2030)
2.3 Chondroitin by Type
2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
2.3.2 Food Grade
2.3.3 Pharmaceutical Grade
2.4 Chondroitin by Application
2.4.1 Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
2.4.2 Pharmacy
2.4.3 Health Products
3 Market Competitive Landscape by Manufacturers
3.1 Global Chondroitin Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global Chondroitin Sales (Ton) of Manufacturers (2019-2024)
3.3 Global Chondroitin Revenue of Manufacturers (2019-2024)
3.4 Global Chondroitin Average Price by Manufacturers (2019-2024)
3.5 Global Chondroitin Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of Chondroitin, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Chondroitin, Product Type & Application
3.8 Global Manufacturers of Chondroitin, Date of Enter into This Industry
3.9 Global Chondroitin Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 SANXIN
4.1.1 SANXIN Company Information
4.1.2 SANXIN Business Overview
4.1.3 SANXIN Chondroitin Sales, Revenue and Gross Margin (2019-2024)
4.1.4 SANXIN Chondroitin Product Portfolio
4.1.5 SANXIN Recent Developments
4.2 Focus Chem
4.2.1 Focus Chem Company Information
4.2.2 Focus Chem Business Overview
4.2.3 Focus Chem Chondroitin Sales, Revenue and Gross Margin (2019-2024)
4.2.4 Focus Chem Chondroitin Product Portfolio
4.2.5 Focus Chem Recent Developments
4.3 GGI
4.3.1 GGI Company Information
4.3.2 GGI Business Overview
4.3.3 GGI Chondroitin Sales, Revenue and Gross Margin (2019-2024)
4.3.4 GGI Chondroitin Product Portfolio
4.3.5 GGI Recent Developments
4.4 Guanglong Biochem
4.4.1 Guanglong Biochem Company Information
4.4.2 Guanglong Biochem Business Overview
4.4.3 Guanglong Biochem Chondroitin Sales, Revenue and Gross Margin (2019-2024)
4.4.4 Guanglong Biochem Chondroitin Product Portfolio
4.4.5 Guanglong Biochem Recent Developments
4.5 Hengjie Bio-Pharmaceuticals
4.5.1 Hengjie Bio-Pharmaceuticals Company Information
4.5.2 Hengjie Bio-Pharmaceuticals Business Overview
4.5.3 Hengjie Bio-Pharmaceuticals Chondroitin Sales, Revenue and Gross Margin (2019-2024)
4.5.4 Hengjie Bio-Pharmaceuticals Chondroitin Product Portfolio
4.5.5 Hengjie Bio-Pharmaceuticals Recent Developments
4.6 Huiwen
4.6.1 Huiwen Company Information
4.6.2 Huiwen Business Overview
4.6.3 Huiwen Chondroitin Sales, Revenue and Gross Margin (2019-2024)
4.6.4 Huiwen Chondroitin Product Portfolio
4.6.5 Huiwen Recent Developments
4.7 ISBA
4.7.1 ISBA Company Information
4.7.2 ISBA Business Overview
4.7.3 ISBA Chondroitin Sales, Revenue and Gross Margin (2019-2024)
4.7.4 ISBA Chondroitin Product Portfolio
4.7.5 ISBA Recent Developments
4.8 Jiaixng Hengjie
4.8.1 Jiaixng Hengjie Company Information
4.8.2 Jiaixng Hengjie Business Overview
4.8.3 Jiaixng Hengjie Chondroitin Sales, Revenue and Gross Margin (2019-2024)
4.8.4 Jiaixng Hengjie Chondroitin Product Portfolio
4.8.5 Jiaixng Hengjie Recent Developments
4.9 Meitek
4.9.1 Meitek Company Information
4.9.2 Meitek Business Overview
4.9.3 Meitek Chondroitin Sales, Revenue and Gross Margin (2019-2024)
4.9.4 Meitek Chondroitin Product Portfolio
4.9.5 Meitek Recent Developments
4.10 Nippon Zoki
4.10.1 Nippon Zoki Company Information
4.10.2 Nippon Zoki Business Overview
4.10.3 Nippon Zoki Chondroitin Sales, Revenue and Gross Margin (2019-2024)
4.10.4 Nippon Zoki Chondroitin Product Portfolio
4.10.5 Nippon Zoki Recent Developments
4.11 Pacific Rainbow
4.11.1 Pacific Rainbow Company Information
4.11.2 Pacific Rainbow Business Overview
4.11.3 Pacific Rainbow Chondroitin Sales, Revenue and Gross Margin (2019-2024)
4.11.4 Pacific Rainbow Chondroitin Product Portfolio
4.11.5 Pacific Rainbow Recent Developments
4.12 Qingdao Green-Extract
4.12.1 Qingdao Green-Extract Company Information
4.12.2 Qingdao Green-Extract Business Overview
4.12.3 Qingdao Green-Extract Chondroitin Sales, Revenue and Gross Margin (2019-2024)
4.12.4 Qingdao Green-Extract Chondroitin Product Portfolio
4.12.5 Qingdao Green-Extract Recent Developments
4.13 QJBCHINA
4.13.1 QJBCHINA Company Information
4.13.2 QJBCHINA Business Overview
4.13.3 QJBCHINA Chondroitin Sales, Revenue and Gross Margin (2019-2024)
4.13.4 QJBCHINA Chondroitin Product Portfolio
4.13.5 QJBCHINA Recent Developments
4.14 Runxin Biotechnology
4.14.1 Runxin Biotechnology Company Information
4.14.2 Runxin Biotechnology Business Overview
4.14.3 Runxin Biotechnology Chondroitin Sales, Revenue and Gross Margin (2019-2024)
4.14.4 Runxin Biotechnology Chondroitin Product Portfolio
4.14.5 Runxin Biotechnology Recent Developments
4.15 SANXIN GROUP
4.15.1 SANXIN GROUP Company Information
4.15.2 SANXIN GROUP Business Overview
4.15.3 SANXIN GROUP Chondroitin Sales, Revenue and Gross Margin (2019-2024)
4.15.4 SANXIN GROUP Chondroitin Product Portfolio
4.15.5 SANXIN GROUP Recent Developments
4.16 Shandong Dongcheng
4.16.1 Shandong Dongcheng Company Information
4.16.2 Shandong Dongcheng Business Overview
4.16.3 Shandong Dongcheng Chondroitin Sales, Revenue and Gross Margin (2019-2024)
4.16.4 Shandong Dongcheng Chondroitin Product Portfolio
4.16.5 Shandong Dongcheng Recent Developments
4.17 Sioux Pharm
4.17.1 Sioux Pharm Company Information
4.17.2 Sioux Pharm Business Overview
4.17.3 Sioux Pharm Chondroitin Sales, Revenue and Gross Margin (2019-2024)
4.17.4 Sioux Pharm Chondroitin Product Portfolio
4.17.5 Sioux Pharm Recent Developments
4.18 Summit Nutritionals
4.18.1 Summit Nutritionals Company Information
4.18.2 Summit Nutritionals Business Overview
4.18.3 Summit Nutritionals Chondroitin Sales, Revenue and Gross Margin (2019-2024)
4.18.4 Summit Nutritionals Chondroitin Product Portfolio
4.18.5 Summit Nutritionals Recent Developments
4.19 TSI Group
4.19.1 TSI Group Company Information
4.19.2 TSI Group Business Overview
4.19.3 TSI Group Chondroitin Sales, Revenue and Gross Margin (2019-2024)
4.19.4 TSI Group Chondroitin Product Portfolio
4.19.5 TSI Group Recent Developments
4.20 WanTuMing Biological
4.20.1 WanTuMing Biological Company Information
4.20.2 WanTuMing Biological Business Overview
4.20.3 WanTuMing Biological Chondroitin Sales, Revenue and Gross Margin (2019-2024)
4.20.4 WanTuMing Biological Chondroitin Product Portfolio
4.20.5 WanTuMing Biological Recent Developments
4.21 Yantai Dongcheng
4.21.1 Yantai Dongcheng Company Information
4.21.2 Yantai Dongcheng Business Overview
4.21.3 Yantai Dongcheng Chondroitin Sales, Revenue and Gross Margin (2019-2024)
4.21.4 Yantai Dongcheng Chondroitin Product Portfolio
4.21.5 Yantai Dongcheng Recent Developments
4.22 YBCC
4.22.1 YBCC Company Information
4.22.2 YBCC Business Overview
4.22.3 YBCC Chondroitin Sales, Revenue and Gross Margin (2019-2024)
4.22.4 YBCC Chondroitin Product Portfolio
4.22.5 YBCC Recent Developments
4.23 Yibao Group
4.23.1 Yibao Group Company Information
4.23.2 Yibao Group Business Overview
4.23.3 Yibao Group Chondroitin Sales, Revenue and Gross Margin (2019-2024)
4.23.4 Yibao Group Chondroitin Product Portfolio
4.23.5 Yibao Group Recent Developments
5 Global Chondroitin Market Scenario by Region
5.1 Global Chondroitin Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Chondroitin Sales by Region: 2019-2030
5.2.1 Global Chondroitin Sales by Region: 2019-2024
5.2.2 Global Chondroitin Sales by Region: 2025-2030
5.3 Global Chondroitin Revenue by Region: 2019-2030
5.3.1 Global Chondroitin Revenue by Region: 2019-2024
5.3.2 Global Chondroitin Revenue by Region: 2025-2030
5.4 North America Chondroitin Market Facts & Figures by Country
5.4.1 North America Chondroitin Market Size by Country: 2019 VS 2023 VS 2030
5.4.2 North America Chondroitin Sales by Country (2019-2030)
5.4.3 North America Chondroitin Revenue by Country (2019-2030)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Chondroitin Market Facts & Figures by Country
5.5.1 Europe Chondroitin Market Size by Country: 2019 VS 2023 VS 2030
5.5.2 Europe Chondroitin Sales by Country (2019-2030)
5.5.3 Europe Chondroitin Revenue by Country (2019-2030)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Chondroitin Market Facts & Figures by Country
5.6.1 Asia Pacific Chondroitin Market Size by Country: 2019 VS 2023 VS 2030
5.6.2 Asia Pacific Chondroitin Sales by Country (2019-2030)
5.6.3 Asia Pacific Chondroitin Revenue by Country (2019-2030)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Chondroitin Market Facts & Figures by Country
5.7.1 Latin America Chondroitin Market Size by Country: 2019 VS 2023 VS 2030
5.7.2 Latin America Chondroitin Sales by Country (2019-2030)
5.7.3 Latin America Chondroitin Revenue by Country (2019-2030)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Chondroitin Market Facts & Figures by Country
5.8.1 Middle East and Africa Chondroitin Market Size by Country: 2019 VS 2023 VS 2030
5.8.2 Middle East and Africa Chondroitin Sales by Country (2019-2030)
5.8.3 Middle East and Africa Chondroitin Revenue by Country (2019-2030)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 Segment by Type
6.1 Global Chondroitin Sales by Type (2019-2030)
6.1.1 Global Chondroitin Sales by Type (2019-2030) & (Ton)
6.1.2 Global Chondroitin Sales Market Share by Type (2019-2030)
6.2 Global Chondroitin Revenue by Type (2019-2030)
6.2.1 Global Chondroitin Sales by Type (2019-2030) & (US$ Million)
6.2.2 Global Chondroitin Revenue Market Share by Type (2019-2030)
6.3 Global Chondroitin Price by Type (2019-2030)
7 Segment by Application
7.1 Global Chondroitin Sales by Application (2019-2030)
7.1.1 Global Chondroitin Sales by Application (2019-2030) & (Ton)
7.1.2 Global Chondroitin Sales Market Share by Application (2019-2030)
7.2 Global Chondroitin Revenue by Application (2019-2030)
7.2.1 Global Chondroitin Sales by Application (2019-2030) & (US$ Million)
7.2.2 Global Chondroitin Revenue Market Share by Application (2019-2030)
7.3 Global Chondroitin Price by Application (2019-2030)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Chondroitin Value Chain Analysis
8.1.1 Chondroitin Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Chondroitin Production Mode & Process
8.2 Chondroitin Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Chondroitin Distributors
8.2.3 Chondroitin Customers
9 Global Chondroitin Analyzing Market Dynamics
9.1 Chondroitin Industry Trends
9.2 Chondroitin Industry Drivers
9.3 Chondroitin Industry Opportunities and Challenges
9.4 Chondroitin Industry Restraints
10 Report Conclusion
11 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings